These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 8514588)
21. Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006. Bhattaram VA; Bonapace C; Chilukuri DM; Duan JZ; Garnett C; Gobburu JV; Jang SH; Kenna L; Lesko LJ; Madabushi R; Men Y; Powell JR; Qiu W; Ramchandani RP; Tornoe CW; Wang Y; Zheng JJ Clin Pharmacol Ther; 2007 Feb; 81(2):213-21. PubMed ID: 17259946 [TBL] [Abstract][Full Text] [Related]
22. AHI perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots. Apley MD J Am Vet Med Assoc; 1995 Oct; 207(7):901-2; discussion 902-4. PubMed ID: 7559022 [No Abstract] [Full Text] [Related]
23. A strike against preemption. Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422 [TBL] [Abstract][Full Text] [Related]
24. Pros and cons of off-label promotion investigations and prosecutions. Loucks MK Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041 [No Abstract] [Full Text] [Related]
25. Congress considers minor use/minor species bill. J Am Vet Med Assoc; 2001 Jul; 219(1):7-8. PubMed ID: 11439774 [No Abstract] [Full Text] [Related]
26. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities. Mann CJ J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581 [No Abstract] [Full Text] [Related]
27. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
28. Extra-label drug use--veterinary practitioner views: companion animals. Cleland JL J Am Vet Med Assoc; 1993 May; 202(10):1642-4;discussion 1654-58. PubMed ID: 8514572 [No Abstract] [Full Text] [Related]
29. [Survey of 50 years of veterinary remedy provision in the Netherlands]. van den Bos T Tijdschr Diergeneeskd; 1998 Dec; 123(24):743-8. PubMed ID: 9879623 [TBL] [Abstract][Full Text] [Related]
30. Clinical trials from the industry viewpoint. McKinley RE J Am Vet Med Assoc; 1972 Dec; 161(11):1391-4. PubMed ID: 4638519 [No Abstract] [Full Text] [Related]
31. An update on the therapeutic orphan. Wilson JT Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794 [No Abstract] [Full Text] [Related]
33. [Off-label use and the 'explanation']. Kamphuis A; de Groot SJ Tijdschr Diergeneeskd; 2003 May; 128(10):340-1. PubMed ID: 12793041 [No Abstract] [Full Text] [Related]
34. Thoughts on the Schuyler and Algon bulk-drug issue. Stribling J J Am Vet Med Assoc; 1988 Oct; 193(8):918-9. PubMed ID: 3192471 [No Abstract] [Full Text] [Related]
35. More animal drugs for minor uses, minor species. J Am Vet Med Assoc; 2008 Jan; 232(2):187-8. PubMed ID: 18275382 [No Abstract] [Full Text] [Related]
36. Drug use guidelines for veterinary practitioners. Gloyd JS J Am Vet Med Assoc; 1993 May; 202(10):1738-9;discussion 1740-1. PubMed ID: 8514600 [No Abstract] [Full Text] [Related]
37. Extra-label drug use--veterinary practitioner views: food animals. Johnson DE J Am Vet Med Assoc; 1993 May; 202(10):1645-7;discussion 1654-8. PubMed ID: 8514573 [No Abstract] [Full Text] [Related]
38. The Minor Use and Minor Species Animal Health Act: past, present, and future. Haley CJ Food Drug Law J; 2006; 61(1):13-43. PubMed ID: 16838456 [No Abstract] [Full Text] [Related]
39. The AVMA legislative initiative: a legal overview. Stribling JH J Am Vet Med Assoc; 1993 May; 202(10):1671-4;discussion 1684-92. PubMed ID: 8514580 [No Abstract] [Full Text] [Related]
40. AVMA legislation: partial solution to drug availability problem. Gloyd JS J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]